CMS questions for Provenge
The Centers for Medicare and Medicaid have posted the questions they wish answered before determining if Provenge will be a reimbursable treatment for prostate cancer. Provenge questions
Advanced Prostate Cancer Teleconference
Malecare Advanced Prostate Cancer Teleconference A conversation about treating advanced stage prostate cancer, with James M. McKiernan, M.D. and Joel Nowak, M.A., M.S.W. Dr. McKiernan is Vice Chairman of the Department and Director of Urologic Oncology at New York - Presbyterian Hospital/Columbia University Medical Center. He treats many patients with high risk cancer diagnoses. Dr. [...]
Clinical Trials That Exclude Gay and Lesbian Patients
The March 18, 2010 issue of *New England Journal of Medicine* (Volume 362, #11, March 18) includes a study: "Clinical Trials That Explicitly Exclude Gay and Lesbian Patients." The authors are Brian L. Egleston, Ph.D., Roland L. Dunbrack, Jr., Ph.D., & Michael J. Hall, M.D. Here's how the report starts: "We recently encountered proposed studies [...]
American Cancer Society Updates Prostate Cancer Screening Guidelines.
Here is the latest American Cancer Society Prostate Cancer Screening Guidelines press release. Please leave comments about these guidelines, by clicking to comment here Update Reaffirms the Importance of Shared Decision-Making ATLANTA –March 3, 2010 – Newly updated prostate cancer screening guidelines from the American Cancer Society reaffirm the recommendation that men should discuss the [...]
Malecare Testimony at Congressional Prostate Cancer Hearing
To: The House Committee on Oversight and Government Reform Re: “Prostate Cancer: New Questions About Screening and Treatment” March 4, 2010 We wish to thank the Committee for allowing us to present four important issues, on behalf of the thousands of men, their loved ones and their families, whom Malecare serves. Founded in 1998, Malecare [...]